Clinical Trial to Assess Effect of Verapamil on Systemic Exposure of EP395 and Effect of EP395 on Systemic Exposure of Midazolam and Digoxin
Clinical trial NCT06118684 · COMPLETED
Trial details
- NCT number
- NCT06118684
- Sponsor
- EpiEndo Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-23
- Primary completion
- 2024-01-02
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.